Supreme Court Rejects ‘Pharma Bro’ Shkreli’s Appeal of Fraud Conviction

Supreme Court Rejects ‘Pharma Bro’ Shkreli’s Appeal of Fraud Conviction
Former pharmaceutical executive Martin Shkreli departs the U.S. District Court for the Eastern District of New York in New York City on Aug. 3, 2017. Drew Angerer/Getty Images
|Updated:

The U.S. Supreme Court has refused to take up the appeal case of Martin Shkreli, the disgraced former pharmaceutical executive who was convicted of defrauding investors.

The high court’s decision on Nov. 18 effectively upholds Shkreli’s seven-year prison sentence and a fine of about $7.4 million.